Therapeutics News

Many chronic pain patients ignore labels on over-the-counter pain relievers and increase their risk for overdose and gastrointestinal side effects, according to results from a new AGA survey.

The ibopamine provocative test may detect an increased risk of glaucoma at an early stage of the disease, according to a study.

Researchers highlight the need for more education on the use of marijuana in treating glaucoma in a study from JAMA Ophthalmology.

Researchers observed a higher fluconazole release in the vial compared with an eye model, as well as differences in drug release among contact lens materials.

Trxade Group Inc. and its subsidiary, Westminster Pharmaceuticals LLC, have launched brimonidine solution 0.2% as part of an exclusive agreement with Indoco Remedies Ltd., according to a press release from the company.

Ranibizumab is a viable treatment option for people with proliferative diabetic retinopathy, according to results from a clinical trial funded by the National Institutes of Health.

Enrollment is underway for a second phase 3 clinical trial of Dextenza sustained release dexamethasone for treatment of allergic conjunctivitis, according to a press release from Ocular Therapeutix.

Pfizer and Allergan announced today that their boards of directors have approved a definitive merger agreement in which Pfizer will combine with Allergan.

Researchers found that prostaglandins lowered intraoperative pressure at 3 months better than beta-blockers, alpha-agonists or carbonic anhydrase in 114 clinical trials on primary open-angle glaucoma treatment.

It is a condition once considered relatively rare, but has now been diagnosed in upwards of 30 million Americans, with as many as 30 million more affected. It is a condition once thought to involve only the elderly or those with severe autoimmune disease (Sjögren’s), but is now recognized among a much wider demographic. It is a condition once considered more of a “nuisance,” but is now viewed as a chronically debilitating disease with huge quality of life implications.